NAMI vs ZYBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

NAMI

55.2
AI Score
VS
ZYBT Wins

ZYBT

59.5
AI Score

Investment Advisor Scores

NAMI

55score
Recommendation
BUY

ZYBT

60score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric NAMI ZYBT Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -31.9% -40.9% NAMI
Earnings Growth 0.0% -79.6% NAMI
Tradestie Score 55.2/100 59.5/100 ZYBT
Profit Margin -23.9% -60.0% NAMI
Beta 1.00 1.00 Tie
AI Recommendation BUY STRONG BUY ZYBT

Relative Price Performance (Last 90 Days)

NAMI 1M: -24.2% · 3M: -46.6% ZYBT 1M: -13.9% · 3M: -7.5%

Current Technical Phase

NAMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.0%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $1.66

ZYBT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 55.3 · Price: $1.49

Fundamentals Snapshot

Metric NAMI ZYBT
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E 0.9 —
Revenue (TTM) — —
Revenue Growth -0.3% -0.4%
Gross Margin 0.1% 0.2%
Operating Margin -0.1% -0.8%
EPS 1.93 -0.20
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZYBT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.